The tumor necrosis factor (TNF) inhibitors have been successfully used in the treatment of sarcoidosis, with improvement noted in recalcitrant cutaneous lesions.1,2
We report 5 cases of cutaneous sarcoidosis treated with TNF inhibitors, including 2 patients who had an excellent response to adalimumab and 3 patients demonstrating significant improvement in their cutaneous lesions after treatment with infliximab. The Table provides a summary of the clinical characteristics and prior treatments of these patients.